Rainbow Children's Medicare Limited

Informe acción NSEI:RAINBOW

Capitalización de mercado: ₹159.8b

Rainbow Children's Medicare Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Rainbow Children's Medicare de 23.2% y 17.6% por año respectivamente. Se prevé que el BPA crezca en un 22.6% al año. Se espera que la rentabilidad financiera sea de 19.7% en 3 años.

Información clave

23.2%

Tasa de crecimiento de los beneficios

22.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare27.4%
Tasa de crecimiento de los ingresos17.6%
Rentabilidad financiera futura19.7%
Cobertura de analistas

Good

Última actualización30 Oct 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Oct 30
Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Is Rainbow Children's Medicare (NSE:RAINBOW) A Risky Investment?

Sep 24
Is Rainbow Children's Medicare (NSE:RAINBOW) A Risky Investment?

Some Confidence Is Lacking In Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E

Sep 06
Some Confidence Is Lacking In Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E

Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Aug 16
Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Rainbow Children's Medicare (NSE:RAINBOW) Is Experiencing Growth In Returns On Capital

Jun 26
Rainbow Children's Medicare (NSE:RAINBOW) Is Experiencing Growth In Returns On Capital

Rainbow Children's Medicare (NSE:RAINBOW) Strong Profits May Be Masking Some Underlying Issues

May 27
Rainbow Children's Medicare (NSE:RAINBOW) Strong Profits May Be Masking Some Underlying Issues

Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report

May 23
Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report

Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

May 07
Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

Some Shareholders Feeling Restless Over Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E Ratio

Mar 20
Some Shareholders Feeling Restless Over Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E Ratio

Returns At Rainbow Children's Medicare (NSE:RAINBOW) Are On The Way Up

Feb 13
Returns At Rainbow Children's Medicare (NSE:RAINBOW) Are On The Way Up

Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

Jan 18
Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)

Nov 07
Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)

Here's Why Rainbow Children's Medicare (NSE:RAINBOW) Has Caught The Eye Of Investors

Oct 18
Here's Why Rainbow Children's Medicare (NSE:RAINBOW) Has Caught The Eye Of Investors

A Look At The Fair Value Of Rainbow Children's Medicare Limited (NSE:RAINBOW)

Aug 29
A Look At The Fair Value Of Rainbow Children's Medicare Limited (NSE:RAINBOW)

With EPS Growth And More, Rainbow Children's Medicare (NSE:RAINBOW) Makes An Interesting Case

Jul 08
With EPS Growth And More, Rainbow Children's Medicare (NSE:RAINBOW) Makes An Interesting Case

Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 18
Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Getting In Cheap On Rainbow Children's Medicare Limited (NSE:RAINBOW) Is Unlikely

Feb 11
Getting In Cheap On Rainbow Children's Medicare Limited (NSE:RAINBOW) Is Unlikely

Are Investors Undervaluing Rainbow Children's Medicare Limited (NSE:RAINBOW) By 24%?

Sep 20
Are Investors Undervaluing Rainbow Children's Medicare Limited (NSE:RAINBOW) By 24%?

Previsiones de crecimiento de beneficios e ingresos

NSEI:RAINBOW - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
3/31/202721,9254,0452,6045,3558
3/31/202618,6883,2232,2894,6599
3/31/202515,5292,5121,9374,1058
9/30/202414,2472,3151,7143,626N/A
6/30/202413,4002,155N/AN/AN/A
3/31/202412,9692,170-3223,214N/A
12/31/202312,7282,196N/AN/AN/A
9/30/202312,4322,154563,299N/A
6/30/202312,2362,136N/AN/AN/A
3/31/202311,7362,1081,8753,288N/A
12/31/202210,6911,690N/AN/AN/A
9/30/202210,1141,5601,2942,248N/A
6/30/20229,6461,405N/AN/AN/A
3/31/20229,7381,3781,6152,237N/A
12/31/20219,2521,2691,8562,454N/A
9/30/20218,5289721,5982,311N/A
6/30/20217,415642N/AN/AN/A
3/31/20216,5004006661,427N/A
3/31/20207,1945499591,704N/A
3/31/20195,4284433981,272N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (23.2% al año) de RAINBOW es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (23.2% al año) de RAINBOW crezcan más rápidamente que el mercado Indian (18% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de RAINBOW crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (17.6% al año) de RAINBOW crezcan más rápidamente que los del mercado Indian (10.5% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 17.6% al año) de RAINBOW crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de RAINBOW sea baja dentro de 3 años (19.7%).


Descubre empresas en crecimiento